Category Archives: Patent Eligible Subject Matter

Genetic Technologies v. LabCorp. – Mayo Redux.

Posted on September 16, 2014 by Warren Woessner

It was Mayo redux with a vengeance in the September 23, 2014 decision in Genetic Technologies Ltd. v. Laboratory Corp. of Amer. Holdings et al., Civil Action No. 12-1736-LPS-CJB (D. Del. 2014). Magistrate Judge Burke released an opinion invalidating claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Genetic Technologies, Judge Burke, Laboratory Corporation, Mayo v Prometheus, Supreme Court, USPTO, Warren Woessner | 2 Comments

FDA’s New Biosimilars Guidance

Posted on August 11, 2014 by Warren Woessner

The following has been posted with the permission of their authors James E. Valentine and James C. Shehan of Hyman, Phelps & McNamara as part of their FDA Law Blog. *** August 09, 2014 FDA’s New Biosimilars Guidance Has Sponsors … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Biosimilars, biotechnology law, FDA, FDA Law Blog, intellectual property, ip, James Shehan, James Valentine, Patent Law, patents, Warren Woessner | Leave a comment

USPTO TRIPs over Myriad-Mayo guidance

Posted on July 31, 2014 by Warren Woessner

Timothy W. Roberts, Chartered Patent Attorney; MA (Oxon); LL.D (honoris causa, Sheffield University) Paul G. Cole, Chartered Patent Attorney; MA (Oxon); LLM, NottinghamTrent; Visiting Professor, Bournemouth University The above UK-based European Practitioners have today filed comments at the USPTO arguing … Continue reading →